Matches in Wikidata for { <http://www.wikidata.org/entity/Q92542330> ?p ?o ?g. }
Showing items 1 to 41 of
41
with 100 items per page.
- Q92542330 description "artículu científicu espublizáu n'agostu de 2019" @default.
- Q92542330 description "scientific article published on 01 August 2019" @default.
- Q92542330 description "wetenschappelijk artikel" @default.
- Q92542330 description "наукова стаття, опублікована 1 серпня 2019" @default.
- Q92542330 name "Confirmation of a new therapeutic option for aggressive or dopamine agonist-resistant prolactin pituitary neuroendocrine tumors" @default.
- Q92542330 name "Confirmation of a new therapeutic option for aggressive or dopamine agonist-resistant prolactin pituitary neuroendocrine tumors" @default.
- Q92542330 type Item @default.
- Q92542330 label "Confirmation of a new therapeutic option for aggressive or dopamine agonist-resistant prolactin pituitary neuroendocrine tumors" @default.
- Q92542330 label "Confirmation of a new therapeutic option for aggressive or dopamine agonist-resistant prolactin pituitary neuroendocrine tumors" @default.
- Q92542330 prefLabel "Confirmation of a new therapeutic option for aggressive or dopamine agonist-resistant prolactin pituitary neuroendocrine tumors" @default.
- Q92542330 prefLabel "Confirmation of a new therapeutic option for aggressive or dopamine agonist-resistant prolactin pituitary neuroendocrine tumors" @default.
- Q92542330 P1433 Q92542330-0D58D335-7A7E-41C9-9579-4D1A100FF8A8 @default.
- Q92542330 P1476 Q92542330-4C88C5AE-4ABF-4396-82FF-7ECB5C436C71 @default.
- Q92542330 P2093 Q92542330-0638D536-A475-4B6E-9F19-047C4B56558C @default.
- Q92542330 P2093 Q92542330-4FB7239F-5085-4CE5-8F4E-E6B8EFD248A4 @default.
- Q92542330 P2093 Q92542330-701961F7-790E-42F9-B222-DD3BBC5044DF @default.
- Q92542330 P2093 Q92542330-C202F868-2B3A-4056-B542-2E04D9063356 @default.
- Q92542330 P304 Q92542330-3E22E885-B42C-4745-BFF8-5AAADB4A8962 @default.
- Q92542330 P31 Q92542330-5c8b5b3f-621e-4ae8-96b8-e0853d8873fc @default.
- Q92542330 P31 Q92542330-BCD49D58-9E0C-493F-B4BA-9FD9E7B66CC5 @default.
- Q92542330 P356 Q92542330-73D880FB-C777-41F6-AB0E-BA695488FB30 @default.
- Q92542330 P433 Q92542330-E3CEE9B4-EBEB-4025-8B02-3C477B316667 @default.
- Q92542330 P478 Q92542330-39B76442-1008-4C95-A465-4D4E6E98F7DA @default.
- Q92542330 P577 Q92542330-C9351D8A-8654-4260-9E00-1E8C2A420D8D @default.
- Q92542330 P698 Q92542330-2803CF9B-28C1-454F-B296-D41B0F77368A @default.
- Q92542330 P356 EJE-19-0359 @default.
- Q92542330 P698 31167164 @default.
- Q92542330 P1433 Q3060778 @default.
- Q92542330 P1476 "Confirmation of a new therapeutic option for aggressive or dopamine agonist-resistant prolactin pituitary neuroendocrine tumors" @default.
- Q92542330 P2093 "Alexandre Vasiljevic" @default.
- Q92542330 P2093 "Emmanuel Jouanneau" @default.
- Q92542330 P2093 "Gerald Raverot" @default.
- Q92542330 P2093 "Hélène Lasolle" @default.
- Q92542330 P304 "C1-C3" @default.
- Q92542330 P31 Q13442814 @default.
- Q92542330 P31 Q7318358 @default.
- Q92542330 P356 "10.1530/EJE-19-0359" @default.
- Q92542330 P433 "2" @default.
- Q92542330 P478 "181" @default.
- Q92542330 P577 "2019-08-01T00:00:00Z" @default.
- Q92542330 P698 "31167164" @default.